F2G
PrivateLast Round
Series H
Sep 12, 2024
Total Funding Raised
$103.45M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
F2G is a biotechnology company that develops novel therapies for the treatment of life-threatening invasive fungal infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
F2G Comparables
Compare F2G with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biosergen AB | 84% | |
| Basilea Pharmaceutica | 80% | |
| Scynexis Inc | 78% |
F2G Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series H | Sep 12, 2024 | ||||
| VC Round | Aug 4, 2022 | ||||
| Series F | Aug 12, 2020 | ||||
| VC Round | Jan 7, 2019 | ||||
| Debt | Nov 22, 2018 | ||||
VC Round | Jun 20, 2016 |
F2G Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Heartcore Capital | VC Round |
| Owl Rock Capital Group | Series H |
| AMR Action Fund | Series H |
| Brace Pharma Capital | Series H, VC Round, Series F |
| Forbion | Series H, VC Round |
| BankInvest | Series A |
| Intermediate Capital Group | Series H |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2026
Open roles increased to 17, 2.3x the trailing average.
- Aug 21, 2026
Monthly visitors increased 185% MoM to 5.2K.
Recent news
Latest coverage and updates
- attends_eventSep 1, 2026
F2G Ltd. will attend event MSGERC 2026 Biennial Meeting on Sep 9th '26.
F2G Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about F2G's valuation, stock price, and market status.
Is F2g a public or private company?
F2g is a private company.
What is the current stock price of F2g?
F2g is a private company with no public stock price. No recent secondary market data is available.
How much is F2g worth (valuation)?
Valuation information for F2g is not publicly available.
Can I buy F2g stock?
F2g shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was F2g's last funding round?
F2g's most recent funding round was Series H on September 12, 2024.
Who are the main investors in F2g?
Key investors in F2g include AMR Action Fund, BankInvest, Intermediate Capital Group, Advent Life Sciences, TD Securities.
Will F2g IPO soon?
No public IPO plans have been announced for F2g.
How can I track F2g secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor F2g's secondary market activity and sign up for updates.